Comparative study between tobramicin and tobramicin plus ciprofloxacin in transrectal prostate biopsy prophylaxis;Estudio comparativo entre tobramicina y tobramicina más ciprofloxacino como profilaxis para la biopsia transrectal de próstata

Actas Urologicas Espanolas

Volumn 30, Issue 9, 2006, Pages 866-870

  Bosquet Sanz, M ^a   Gimeno Argente, V ^a   Arlandis Guzman S ^a   Bonillo Garcia M A ^a   Trassierra Villa, M ^a   Jimenez Cruz J F ^a  

^a HOSPITAL UNIVERSITARIO LA FE   (Spain)

Author keywords

Ultrasound guided transrectal prostatic biopsy

Indexed keywords

ANTIINFECTIVE AGENT; CIPROFLOXACIN; TOBRAMYCIN;

AGED; ANTIBIOTIC PROPHYLAXIS; ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HUMAN; MALE; NEEDLE BIOPSY; PATHOLOGY; PROSPECTIVE STUDY; PROSTATE; RANDOMIZED CONTROLLED TRIAL;

AGED; ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS; ANTIBIOTIC PROPHYLAXIS; BIOPSY, NEEDLE; CIPROFLOXACIN; HUMANS; MALE; PROSPECTIVE STUDIES; PROSTATE; TOBRAMYCIN;

EID: 34347238273     PISSN: 02104806     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0210-4806(06)73552-5     Document Type: Article

References (10)

1. Santos Arrontes D, Luján Galán M, Pascual Mateo C, Chiva Robles V, Fernández González I, Berenguer Sánchez A. Análisis descriptivo de los efectos adversos asociados a la biopsia transrectal de próstata después de 603 procedimientos. Arch Esp Urol. 2004;57(6):601-605.
2. Borer A, Gilad J, Sikuler E, Riesenberg K, Schlaeffer F, Buskila D. Fatal Clostridium sordellii ischiorectal abscess with septicaemia complicating ultrasoundguided transrectal prostate biopsy. J Infect. 1999;38(2):128-129.
3. Tal R, Livne PM, Lask DM, Daniel J. Empirical management of urinary tract Infections complicating transrectal ultrasound guided prostate biopsy. J Urol. 2003;169(5): 1762-1765.
4. www.ine.es.
5. Herranz Amo F, Rodriguez Fernandez E, Diez Cordero JM, Lledo Garcia E, Verdu Tartajo F, Gonzalez Chamorro F, Subira Castillon C. Morbidity of and tolerance to ultrasonography-guided transrectal biopsy of the prostate. Actas Urol Esp. 1996;20(10):858-866.
6. Rietbergen JB, Boeken Kruger AE, Kranse R, Schröeder FH. Complications of trasrectal ultrasound-guided systematic sextant biopsies of the prostate: evaluation of complication rates and risk factors within a population-based screening program. Urology. 1997;49(6):875-880.
7. Enlund AL, Varenhorst E. Morbidity of ultrasound-guided transrectal core biopsy of the prostate without prophylactic antibiotic therapy. A prospective study in 415 cases. Br J Urol. 1997;79(5):777-780.
8. Raaijmakers R, Kirkels WJ, Roobol MJ, Wildhagen MF, Schrder FH. Complication rates and risk factors of 5802 transrectal ultrasound-guided sextant biopsies of the prostate within a population-based screening program. Urology 2002;60(5):826-830.
9. Shandera KC, Thibault GP, Deshon GE. Efficacy of one dose fluorquinolone before prostate biopsy. Urology 1998;52(4):641-643.
10. Toblas-Machado M, Correa TD, De Barros EL, Wroclawski ER. Antibiotic prophylaxis in prostate biopsy. A comparative randomized clinical assay between ciprofloxacin, norfloxacin and chloramphenicol. Int Braz J Urol. 2003;29(4): 313-319.